Empresa PURE Bioscience, Inc. Other OTC
Acciones
PURE
US74621T2096
Productos para el hogar
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pure Hard Surface
95,2
%
| 1 | 80,8 % | 2 | 95,2 % | +19,23 % |
Silverion
4,5
%
| 0 | 17,0 % | 0 | 4,5 % | -73,02 % |
Royalty
0,3
%
| 0 | 2,2 % | 0 | 0,3 % | -85,00 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | +1,30 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/02/23 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 01/01/04 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/98 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09/05/11 |
Tom Lee
BRD | Director/Board Member | 75 | 24/10/14 |
John Kasperski
SAM | Sales & Marketing | - | 01/04/22 |
Zhinong Yan
PRN | Corporate Officer/Principal | - | 01/05/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/02/23 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09/05/11 |
Tom Lee
BRD | Director/Board Member | 75 | 24/10/14 |
Ivan Chen
CHM | Chairman | 41 | 28/06/18 |
David Rendall
BRD | Director/Board Member | 51 | 27/01/21 |
Bernard Blotner
BRD | Director/Board Member | 73 | 08/02/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 111 856 473 | 66 608 527 ( 59,55 %) | 0 | 59,55 % |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
-17,42 % | 39,57 mil M | |
+12,21 % | 25,95 mil M | |
-26,35 % | 6177,75 M | |
+6,07 % | 5982,43 M | |
-3,79 % | 3117,24 M | |
+7,64 % | 2545,74 M | |
-11,61 % | 1863,82 M | |
+25,31 % | 954 M | |
-3,28 % | 642 M |